Logotype for Zepp Health Corporation

Zepp Health (ZEPP) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Zepp Health Corporation

Q3 2024 earnings summary

13 Jan, 2026

Executive summary

  • Q3 2024 revenue was $42.5 million, down 48.9% year-over-year, with 0.7 million units shipped, mainly due to lower Xiaomi and self-branded product sales amid supply constraints and macroeconomic weakness.

  • Achieved highest sequential growth in self-branded sales for 2024, up 9.9% quarter-over-quarter, contributing over 95% of total revenue, driven by new launches like the T-Rex 3 smartwatch.

  • Gross margin reached a record 40.6%, up from 33.9% a year ago, marking the sixth consecutive quarter of expansion.

  • Net loss attributable to Zepp was $13.3 million in Q3 2024; adjusted net loss was $12.6 million.

  • Ongoing product innovation and ecosystem expansion with launches like Amazfit Helio Ring, Up earbuds, and new marketing partnerships.

Financial highlights

  • Q3 2024 revenue was $42.5 million, down from $83.1 million in Q3 2023; units shipped fell to 0.7 million from 2.8 million.

  • Gross margin: 40.6% in Q3 2024, the highest in company history.

  • Operating costs for Q3 were $29 million, including a $1 million foreign exchange loss; excluding FX, costs were $28 million.

  • R&D expenses: $10.9 million (25.6% of revenue), selling/marketing: $11.9 million (28.0% of revenue), G&A: $7.0 million (16.5% of revenue), all up year-over-year.

  • Cash and cash equivalents stood at $127.7 million as of September 30, 2024, stable sequentially.

Outlook and guidance

  • Q4 2024 net revenues expected between $55 million and $70 million, with self-branded products projected to contribute over 90% of revenue and grow 29%–65% sequentially.

  • Anticipates higher Q4 sales due to resolved supply constraints, seasonal demand, and new product launches.

  • Expects continued margin expansion and improved profitability as cost management and product mix improvements persist.

  • Focus areas include international expansion, new product releases, and strict cost control.

  • Plans for a more balanced product launch cadence in 2025, with major product line renewals each quarter.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more